Finch Therapeutics Group Inc
OTC:FNCH
Finch Therapeutics Group Inc
OTC:FNCH
Price:
8.35
USD
-4.02%
Market Closed
Market Cap:
$13.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Finch Therapeutics Group Inc
OTC:FNCH
|
US |
|
O
|
Openedges Technology Inc
KOSDAQ:394280
|
KR |
|
Beijing Zhongkehaixun Digital S&T Co Ltd
SZSE:300810
|
CN |
|
X
|
XP Chemistries AB
STO:XPC
|
SE |
|
Decision Diagnostics Corp
OTC:DECN
|
US |
|
MS Holdings Ltd
SGX:40U
|
SG |
Cash Flow Statement
Cash Flow Statement
Finch Therapeutics Group Inc
Finch Therapeutics Group Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(39)
|
(45)
|
(52)
|
(52)
|
(58)
|
(69)
|
(76)
|
(107)
|
(115)
|
(154)
|
(137)
|
(99)
|
(75)
|
(15)
|
(14)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
2
|
2
|
3
|
4
|
5
|
6
|
6
|
4
|
3
|
2
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
3
|
3
|
4
|
6
|
4
|
6
|
5
|
5
|
8
|
5
|
5
|
4
|
2
|
1
|
0
|
|
| Other Non-Cash Items |
3
|
3
|
2
|
4
|
3
|
5
|
9
|
28
|
36
|
83
|
80
|
60
|
51
|
1
|
2
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
4
|
0
|
(8)
|
(17)
|
(15)
|
(17)
|
(6)
|
(1)
|
(2)
|
6
|
(0)
|
(3)
|
(5)
|
(9)
|
(6)
|
|
| Cash from Operating Activities |
(31)
N/A
|
(41)
-29%
|
(56)
-39%
|
(64)
-13%
|
(67)
-6%
|
(78)
-16%
|
(70)
+10%
|
(74)
-7%
|
(75)
-1%
|
(63)
+16%
|
(56)
+11%
|
(42)
+25%
|
(32)
+25%
|
(22)
+29%
|
(18)
+20%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(3)
|
(11)
|
(14)
|
(16)
|
(16)
|
(8)
|
(6)
|
(4)
|
(2)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Cash from Investing Activities |
(3)
N/A
|
(11)
-333%
|
(14)
-22%
|
(16)
-15%
|
(16)
+1%
|
(8)
+50%
|
(6)
+23%
|
(4)
+33%
|
(2)
+47%
|
(1)
+41%
|
1
N/A
|
1
+40%
|
1
+8%
|
1
+1%
|
0
-95%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
90
|
209
|
209
|
119
|
119
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
2
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
15
|
15
|
15
|
(0)
|
(15)
|
(15)
|
(15)
|
0
|
0
|
|
| Other |
(0)
|
(2)
|
0
|
0
|
0
|
2
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
|
| Cash from Financing Activities |
91
N/A
|
209
+128%
|
209
0%
|
119
-43%
|
119
+0%
|
2
-99%
|
15
+751%
|
15
N/A
|
15
0%
|
(1)
N/A
|
(16)
-1 136%
|
(16)
0%
|
(16)
0%
|
0
N/A
|
0
N/A
|
|
| Change in Cash | ||||||||||||||||
| Net Change in Cash |
58
N/A
|
157
+173%
|
139
-12%
|
39
-72%
|
36
-8%
|
(84)
N/A
|
(61)
+27%
|
(64)
-4%
|
(62)
+2%
|
(65)
-5%
|
(71)
-9%
|
(57)
+20%
|
(46)
+19%
|
(21)
+54%
|
(18)
+15%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(34)
N/A
|
(52)
-53%
|
(70)
-35%
|
(80)
-14%
|
(83)
-4%
|
(86)
-3%
|
(76)
+12%
|
(78)
-4%
|
(77)
+2%
|
(64)
+17%
|
(56)
+12%
|
(42)
+25%
|
(32)
+25%
|
(22)
+29%
|
(18)
+20%
|
|
Switch to:
Switch to:
See Also
Discover More
